Effect of treatment of malignant disease on growth in children.
Open Access
- 1 August 1980
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 55 (8) , 600-603
- https://doi.org/10.1136/adc.55.8.600
Abstract
The growth of 95 children with malignant disease was studied over a 3- or 4-year period, and compared with the growth of normal children matched for age and sex by calculation of the standard deviation score. The mean standard deviation score of the children with leukaemia fell in the first year of treatment, and thereafter showed little change, remaining below the normal. This effect was related to cranial and craniospinal irradiation, but not to age or duration of chemotherapy. The loss in eventual height attained was small and does not suggest any long-term interference with growth hormone production.This publication has 7 references indexed in Scilit:
- ENDOCRINE MORBIDITY IN ADULTS TREATED WITH CEREBRAL IRRADIATION FOR BRAIN TUMOURS DURING CHILDHOODActa Endocrinologica, 1977
- Growth hormone deficiency after treatment of acute leukaemia in children.Archives of Disease in Childhood, 1976
- THE EFFECT OF VARYING DOSES OF CEREBRAL IRRADIATION ON GROWTH HORMONE PRODUCTION IN CHILDHOODClinical Endocrinology, 1976
- RADIATION AND PITUITARY FUNCTION IN CHILDRENThe Lancet, 1975
- The Natural History of the Silver-Russell Syndrome: A Longitudinal Study of Thirty-nine CasesPediatric Research, 1975
- PITUITARY FUNCTION AFTER TREATMENT OF INTRACRANIAL TUMOURS IN CHILDRENThe Lancet, 1975
- Growth retardation in children after megavoltage irradiation of the spineCancer, 1973